An Observational Study to Assess Change in Disease Activity and Adverse Events of Adalimumab in Chinese Pediatric Participants With Polyarticular Juvenile Idiopathic Arthritis (pJIA)
Clinical trial NCT05411211 · COMPLETED
Trial details
- NCT number
- NCT05411211
- Sponsor
- AbbVie
- Status
- COMPLETED
- Study type
- OBSERVATIONAL
- Start date
- 2022-11-10
- Primary completion
- 2024-09-08
- Enrollment
- 20
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.